Northwest Biotherapeutics (NWBO) Picks Up Momentum: A Good Buy?

In recent times, Northwest Biotherapeutics, Inc (OTC: NWBO) stock has emerged as one of the stocks that attracted considerable attention from investors and over the past three weeks, the stock has gained as big as 20%.

Northwest Biotherapeutics (NWBO) Picks Up Momentum: A Good Buy?

In this sort of situation, it could be the right move to have a closer look at the cancer medicine development company and its business. Last month Northwest released its financial results for the third quarter and suffered a loss of as huge as $194 million.

The company further pointed out that the losses worked out to 26 cents a share, but after adjustments, it came down to 7 cents a share. On the other hand, the revenues for the quarter came in at $216,000. Over the course of the past year or so, the stock has recorded remarkable gains. The stock closed at $1.61 a share this past Friday but back in January 2020, it was trading at only 21 cents per share.

Northwest Biotherapeutics (NWBO) Picks Up Momentum: A Good Buy?

Emile Ortega

Editor and Computer ExpertA hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.